Slow Wave Sleep Enhancement with Gaboxadol Reduces Daytime Sleepiness During Sleep Restriction

STUDY OBJECTIVES: To evaluate the impact of enhanced slow wave sleep (SWS) on behavioral, psychological, and physiological changes resulting from sleep restriction. DESIGN: A double-blind, parallel group, placebo-controlled design was used to compare gaboxadol (GBX) 15 mg, a SWS-enhancing drug, to p...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Walsh, James K., Snyder, Ellen, Hall, Janine, Randazzo, Angela C., Griffin, Kara, Groeger, John, Eisenstein, Rhody, Feren, Stephen D., Dickey, Pam, Schweitzer, Paula K.
Format: Artigo
Idioma:Inglês
Publicat: Associated Professional Sleep Societies, LLC 2008
Matèries:
Slow Wave Sleep Enhancement and Daytime Sleepiness
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2398757/
https://ncbi.nlm.nih.gov/pubmed/18517036
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars